Getting Out of the Phosphate Bind: Trials to Guide Treatment Targets
- PMID: 28550079
- PMCID: PMC5460702
- DOI: 10.2215/CJN.04380417
Getting Out of the Phosphate Bind: Trials to Guide Treatment Targets
Keywords: Biophysical Phenomena; Phosphates.
Comment on
-
Two phosphAte taRGets in End-stage renal disease Trial (TARGET): A Randomized Controlled Trial.Clin J Am Soc Nephrol. 2017 Jun 7;12(6):965-973. doi: 10.2215/CJN.10941016. Epub 2017 May 26. Clin J Am Soc Nephrol. 2017. PMID: 28550080 Free PMC article. Clinical Trial.
References
-
- Slatopolsky E, Bricker NS: The role of phosphorus restriction in the prevention of secondary hyperparathyroidism in chronic renal disease. Kidney Int 4: 141–145, 1973 - PubMed
-
- Scialla JJ, Wolf M: Roles of phosphate and fibroblast growth factor 23 in cardiovascular disease. Nat Rev Nephrol 10: 268–278, 2014 - PubMed
-
- Palmer SC, Hayen A, Macaskill P, Pellegrini F, Craig JC, Elder GJ, Strippoli GF: Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: A systematic review and meta-analysis. JAMA 305: 1119–1127, 2011 - PubMed
-
- Kidney Disease Improving Global Outcomes (KDIGO) CKD-MBD Work Group: KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl 113: S1–S130, 2009 - PubMed
-
- National Kidney Foundation: K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 42[4 Suppl 3]: S1–S201, 2003 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
